Factors that influence treatment decisions: A qualitative study of racially and ethnically diverse patients with low- and very-low risk prostate cancer

被引:9
|
作者
Guan, Alice [1 ]
Shim, Janet K. [2 ]
Allen, Laura [1 ]
Kuo, Mei-Chin [1 ]
Lau, Kathie [1 ]
Loya, Zinnia [1 ]
Brooks, James D. [3 ]
Carroll, Peter R. [4 ]
Cheng, Iona [1 ]
Chung, Benjamin I. [3 ]
DeRouen, Mindy C. [1 ]
Frosch, Dominic L. [5 ]
Golden, Todd [1 ]
Leppert, John T. [3 ]
Lichtensztajn, Daphne Y. [1 ]
Lu, Qian [6 ]
Oh, Debora L. [1 ]
Sieh, Weiva [7 ]
Wadhwa, Michelle [1 ]
Gomez, Scarlett L. [1 ]
Shariff-Marco, Salma [1 ,8 ]
机构
[1] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA
[2] Univ Calif San Francisco, Dept Social & Behav Sci, San Francisco, CA USA
[3] Stanford Univ, Dept Urol, Stanford, CA USA
[4] Univ Calif San Francisco, Dept Urol, San Francisco, CA USA
[5] Sutter Hlth Palo Alto Med Fdn Res Inst, Ctr Hlth Syst Res, Palo Alto, CA USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Hlth Dispar Res, Houston, TX USA
[7] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY USA
[8] Univ Calif San Francisco, Dept Epidemiol & Biostat, 550 16 St, San Francisco, CA 94158 USA
来源
CANCER MEDICINE | 2023年 / 12卷 / 05期
基金
美国国家卫生研究院;
关键词
prostate cancer; psychosocial studies; quality of life; translational research; ACTIVE SURVEILLANCE; AFRICAN-AMERICAN; MEN; RACE; SPIRITUALITY; MANAGEMENT; GUIDELINES; RESIDENCE; CARCINOMA; SURVIVORS;
D O I
10.1002/cam4.5405
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundFactors that influence prostate cancer treatment decisions are complex, multifaceted, and personal, and may vary by race/ethnicity. Although research has been published to quantify factors involved in decision-making, these studies have been limited to primarily white, and to a lesser extent, Black patients, and quantitative studies are limited for discerning the cultural and contextual processes that shape decision-making. MethodsWe conducted 43 semi-structured interviews with a racially and ethnically diverse sample of patients diagnosed with low- and very-low risk prostate cancer who had undergone treatment for their prostate cancer. Interviews were transcribed, independently coded, and analyzed to identify themes salient for decision-making, with attention to sociocultural differences. ResultsWe found racial and ethnic differences in three areas. First, we found differences in how socialized masculinity influenced patient's feelings about different treatment options. Second, we found that for some men, religion and spirituality alleviated anxiety associated with the active surveillance protocol. Finally, for racially and ethnically minoritized patients, we found descriptions of how historic and social experiences within the healthcare system influenced decision-making. ConclusionsOur study adds to the current literature by expounding on racial and ethnic differences in the multidimensional, nuanced factors related to decision-making. Our findings suggest that factors associated with prostate cancer decision-making can manifest differently across racial and ethnic groups, and provide some guidance for future research.
引用
收藏
页码:6307 / 6317
页数:11
相关论文
共 50 条
  • [31] SBRT in low- and intermediate-risk prostate cancer: results of a phase II study
    D'Agostino, G.
    Villa, E.
    Franzese, C.
    Liardo, R.
    Reggiori, G.
    Navarria, P.
    Iftode, C.
    De Rose, F.
    Franceschini, D.
    Tozzi, A.
    Comito, T.
    Ascolese, A.
    Tomatis, S.
    Scorsetti, M.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S628 - S629
  • [32] GLEASON SCORE UPGRADING IN NCCN VERY LOW RISK CLASSIFICATION PROSTATE CANCER PATIENTS
    Nazmy, Michael
    Lau, Clayton
    Wilson, Timothy
    Yamzon, Jonathan
    JOURNAL OF UROLOGY, 2012, 187 (04): : E284 - E284
  • [33] AN ASSESSMENT OF FACTORS INFLUENCING PHYSICIANS' TREATMENT RECOMMENDATIONS FOR LOW RISK PROSTATE CANCER
    Bellini, Paula
    Davis, Kimberly M.
    Hagerman, Charlotte
    Zinar, Riley
    Leigh, Daniel
    Leimpeter, Amethyst
    Taylor, Kathryn
    Hoffman, Richard
    Van Den Eeden, Stephen K.
    ANNALS OF BEHAVIORAL MEDICINE, 2016, 50 : S184 - S184
  • [34] PATHOLOGIC OUTCOMES IN PATIENTS AFFECTED BY VERY-LOW-RISK AND LOW-RISK PROSTATE CANCER AND ELIGIBLE FOR ACTIVE SURVEILLANCE
    Napodano, Giorgio
    Realfonso, Tommaso
    Intilla, Olivier
    Pistone, Antonio
    Addesso, Maria
    Sanseverino, Roberto
    ANTICANCER RESEARCH, 2017, 37 (04) : 2081 - 2082
  • [35] Long-term follow-up of a racially and ethnically diverse population of patients with localized prostate cancer who did not undergo initial active treatment
    Slezak, Jeff
    Van Den Eeden, Stephen
    Cannavale, Kimberly L.
    Chein, Gary W.
    Chao, Chun R.
    CANCER RESEARCH, 2019, 79 (13)
  • [36] External evaluation of the Briganti nomogram predicting lymph node invasion in patients with very-low to high risk prostate cancer: A retrospective multi-institutional cohort study in Japan
    Sugihara, Naoya
    Hashine, Katsuyoshi
    Yamashita, Natsumi
    Tachou, Takatoshi
    Kan, Masaharu
    Oka, Akihiro
    Takeda, Hajime
    Miura, Noriyoshi
    Miyauchi, Yuki
    Saika, Takashi
    INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 : 154 - 154
  • [37] Sociodemographic and Clinical Predictors of Switching to Active Treatment among a Large, Ethnically Diverse Cohort of Men with Low Risk Prostate Cancer on Observational Management EDITORIAL COMMENT
    Penson, David F.
    JOURNAL OF UROLOGY, 2016, 196 (03): : 740 - 740
  • [38] Phase 2 Study of Monotherapy Galunisertib (LY2157299 Monohydrate) in Very Low-, Low-, and Intermediate-Risk Patients with Myelodysplastic Syndromes
    Valcarcel, David
    Verma, Amit
    Platzbecker, Uwe
    Santini, Valeria
    Giagounidis, Aristoteles
    Diez-Campelo, Maria
    Janssen, Jan
    Schlenk, Richard F.
    Gaidano, Gianluca
    Perez de Oteyza, Jaime
    Cleverly, Ann L.
    Chiang, Alan Y.
    Lahn, Michael
    Desiaih, Durisala
    Guba, Susan C.
    List, Alan F.
    Komrokji, Rami S.
    BLOOD, 2015, 126 (23)
  • [39] Patient and physician perspectives on treatments for low-risk prostate cancer: a qualitative study
    Guan, Alice
    Santiago-Rodriguez, Eduardo J.
    Chung, Benjamin I.
    Shim, Janet K.
    Allen, Laura
    Kuo, Mei-Chin
    Lau, Kathie
    Loya, Zinnia
    Brooks, James D.
    Cheng, Iona
    Derouen, Mindy C.
    Frosch, Dominick L.
    Golden, Todd
    Leppert, John T.
    Lichtensztajn, Daphne Y.
    Lu, Qian
    Oh, Debora
    Sieh, Weiva
    Wadhwa, Michelle
    Cooperberg, Matthew R.
    Carroll, Peter R.
    Gomez, Scarlett L.
    Shariff-Marco, Salma
    BMC CANCER, 2023, 23 (01)
  • [40] Patient and physician perspectives on treatments for low-risk prostate cancer: a qualitative study
    Alice Guan
    Eduardo J. Santiago-Rodríguez
    Benjamin I. Chung
    Janet K. Shim
    Laura Allen
    Mei-Chin Kuo
    Kathie Lau
    Zinnia Loya
    James D. Brooks
    Iona Cheng
    Mindy C. DeRouen
    Dominick L. Frosch
    Todd Golden
    John T. Leppert
    Daphne Y. Lichtensztajn
    Qian Lu
    Debora Oh
    Weiva Sieh
    Michelle Wadhwa
    Matthew R. Cooperberg
    Peter R. Carroll
    Scarlett L. Gomez
    Salma Shariff-Marco
    BMC Cancer, 23